Tetsuaki Hirase
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 01, 2025
A phase 1 single and multiple ascending dose study of orforglipron in Japanese participants with type 2 diabetes.Kenji Ohwaki, Chino Nakamura, Risa Nasu
|Jul 25, 2025
Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis.Hanaka Mimura, Tomonori Oura, Rina Chin
|Feb 14, 2025
Insulin Sensitivity and Beta-Cell Function Following Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J-mono Analysis.Yoshiyuki Hamamoto, Tomonori Oura, Tetsuaki Hirase
|Oct 05, 2023
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J-mono study.Takeshi Osonoi, Tomonori Oura, Tetsuaki Hirase
Pageof 1
